NCBI PubMed Central
open access
Extracellular matrix-targeted TNC-scFv armoring enhances CAR T cell persistence and antitumor activity in solid tumors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors#1162502
- TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy#261519
- Targeting ZC3H12C improves T cell persistence and antitumor function in adoptive T cell therapy#243486
- Viral Specific T Cell Therapy for COVID-19 Related Pneumonia#1294203
- Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis#859200
Record · ID 1284749
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive